Efficacy and safety of low-dose digoxin in patients with heart failure. Rationale and design of the DECISION trial.

Autor: van Veldhuisen DJ; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Rienstra M; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Mosterd A; Department of Cardiology, Meander Medisch Centrum, Amersfoort, The Netherlands.; Workgroup Cardiology Centers, Utrecht, The Netherlands., Alings AM; Workgroup Cardiology Centers, Utrecht, The Netherlands.; Department of Cardiology, Amphia Medical Center, Breda, The Netherlands., van Asselt ADJ; Department of Epidemiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Bouvy ML; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands., Tijssen JGP; Department of Cardiology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Schaap J; Workgroup Cardiology Centers, Utrecht, The Netherlands.; Department of Cardiology, Amphia Medical Center, Breda, The Netherlands., van der Wall EE; Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands., Voors AA; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Boorsma EM; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Lok DJA; Department of Cardiology, Deventer Hospital, Deventer, The Netherlands., Crijns HJGM; Department of Cardiology and Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands., Schut A; Workgroup Cardiology Centers, Utrecht, The Netherlands., Vijver MAT; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Voordes GHD; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., de Vos AH; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Maas-Soer EL; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Smit NW; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Touw DJ; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Samuel M; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., van der Meer P; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

Publikováno v: European journal of heart failure [Eur J Heart Fail] 2024 Oct; Vol. 26 (10), pp. 2223-2230. Date of Electronic Publication: 2024 Aug 30.

Clinical and proteomic profiles of chronic kidney disease in heart failure with reduced and preserved ejection fraction.

Autor: Voordes GHD; University of Groningen, Department of Cardiology, UMC Groningen, the Netherlands., Voors AA; University of Groningen, Department of Cardiology, UMC Groningen, the Netherlands., Hoegl A; Novo Nordisk, Copenhagen, Denmark., Madsen CT; Novo Nordisk, Copenhagen, Denmark., van Essen BJ; University of Groningen, Department of Cardiology, UMC Groningen, the Netherlands., Ouwerkerk W; Department of Dermatology, Amsterdam UMC, University of Amsterdam, Amsterdam Infection and Immunity Institute, Amsterdam, the Netherlands; Saw Swee Hock School of Public Health and National University of Singapore and National University Health System, Singapore., Tromp J; University of Groningen, Department of Cardiology, UMC Groningen, the Netherlands; Saw Swee Hock School of Public Health and National University of Singapore and National University Health System, Singapore; Duke-NUS Medical School Singapore, Singapore., de la Rambelje MA; University of Groningen, Department of Cardiology, UMC Groningen, the Netherlands., Grønborg M; Novo Nordisk, Copenhagen, Denmark., Refsgaard JC; Novo Nordisk, Copenhagen, Denmark., Lang CC; School of Medicine Centre for Cardiovascular and Lung Biology, Division of Medical Sciences, University of Dundee, Ninewells Hospital & Medical School, Dundee, UK., Barascuk-Michaelsen N; Novo Nordisk, Copenhagen, Denmark., Damman K; University of Groningen, Department of Cardiology, UMC Groningen, the Netherlands. Electronic address: k.damman@umcg.nl.

Publikováno v: International journal of cardiology [Int J Cardiol] 2024 Dec 15; Vol. 417, pp. 132580. Date of Electronic Publication: 2024 Sep 19.